Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines ›RPH Pharmaceuticals AB
Medicines register · Ireland

RPH Pharmaceuticals AB — licensed medicines

8 medicines held by RPH Pharmaceuticals AB on the Irish market, from the HPRA register.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 07 Oct 2026, 03:23 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
8 of 10,296 medicines
Download
Medicine
Active substance
Licence holder
Status
Betnesol 0.1% w/v Eye, Ear and Nasal Drops, solution PA1638/001/001
BETAMETHASONE SODIUM PHOSPHATE
RPH Pharmaceuticals AB
Marketed
Betnesol-N 0.1% w/v, 3500 IU/ml Eye, Ear and Nasal Drops, solution PA1638/002/001
Neomycin sulfate, BETAMETHASONE SODIUM PHOSPHATE
RPH Pharmaceuticals AB
Marketed
Bettamousse 1 mg/g (0.1%) cutaneous foam PA1638/009/001
Betamethasone valerate
RPH Pharmaceuticals AB
Marketed
Cocois Ointment, coal tar 12.0% sulphur for external use 4.0%, salicylic acid 2.0% PA1638/005/001
Coal tar solution, Sulphur for external use, Salicylic acid
RPH Pharmaceuticals AB
Marketed
Neo-Cytamen 1000 micrograms/ml Solution for Injection PA1638/004/001
Hydroxocobalamin
RPH Pharmaceuticals AB
Marketed
Trandate 100mg Film-Coated Tablets PA1638/006/002
Labetalol hydrochloride
RPH Pharmaceuticals AB
Marketed
Trandate 200mg Film-coated Tablets PA1638/006/003
Labetalol hydrochloride
RPH Pharmaceuticals AB
Marketed
Trandate 5 mg/ml Solution for Injection PA1638/006/001
Labetalol hydrochloride
RPH Pharmaceuticals AB
Marketed
Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 7 October 2026. https://priyalifescience.com/medicines/company/rph-pharmaceuticals-ab

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.